Compare Crescent Energy Company Class A Common Stock (CRGY) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crescent Energy Company Class A Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? Crescent Energy Company Class A Common Stock trades at $12.66 (market cap $4.30B), while ImmunityBio Inc. Common Stock trades at $10.51 (market cap $10.51B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 2.4× Crescent Energy Company Class A Common Stock's market cap, and Crescent Energy Company Class A Common Stock pays a 3.69% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Crescent Energy Company Class A Common Stock for 1 Days and ImmunityBio Inc. Common Stock for 1 Days on average.
| CRGY | IBRX | |
|---|---|---|
Market Cap | $4.30B | $10.51B |
Volume | 15,201,625 | 10,445,785 |
Sector | Energy | Health |
52-Week High | $15.37 | $11.55 |
52-Week Low | $7.75 | $1.98 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $9.31B | $10.97B |
Dividend Yield | 3.69% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Crescent Energy Company Class A Common Stock
Crescent Energy acquires, develops, and produces oil and natural gas from onshore U.S. basins. Its portfolio includes producing assets with oil and natural gas exposure.
Read more on CRGY →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
